Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Faeth Therapeutics Inc., 3 years.
Faeth Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 1, 2026 | Faeth Therapeutics Inc. | Open-market sale | −24,524 | $20.00 | $490,480 |
| Jun 1, 2026 | Faeth Therapeutics Inc. | Open-market sale | −476 | $21.14 | $10,063 |
| Dec 9, 2025 | Faeth Therapeutics Inc. | Open-market sale | −2,666 | $7.95 | $21,195 |
| Dec 9, 2025 | Faeth Therapeutics Inc. | Option exercise | +395 | $6.40 | $2,528 |
| Dec 9, 2025 | Faeth Therapeutics Inc. | Open-market sale | −395 | $8.04 | $3,176 |
| Dec 9, 2025 | Faeth Therapeutics Inc. | Open-market sale | −446 | $7.92 | $3,532 |
| Dec 8, 2025 | Faeth Therapeutics Inc. | Open-market sale | −3,105 | $8.59 | $26,672 |
| Dec 5, 2025 | Faeth Therapeutics Inc. | Open-market sale | −14,508 | $11.40 | $165,391 |
| Dec 5, 2025 | Faeth Therapeutics Inc. | Open-market sale | −1,745 | $12.29 | $21,446 |
| Dec 5, 2025 | Faeth Therapeutics Inc. | Open-market sale | −42 | $13.16 | $553 |
| Dec 4, 2025 | Faeth Therapeutics Inc. | Open-market sale | −5,000 | $9.06 | $45,300 |
| Jul 31, 2023 | Faeth Therapeutics Inc. | Sold back to the company | −1,587,302 | $1.26 | $2,000,001 |
| Jul 10, 2023 | Faeth Therapeutics Inc. | Grant or award | +4,466 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.